Market Indices
Sector Heatmap
BBNX — Beta Bionics, Inc. Common Stock
NasdaqBeta Bionics, Inc. Common Stock
- O
- 18.87
- H
- 19.26
- L
- 18.27
- V
- 514.77K
BBNX — Latest News & Headlines
20 StoriesBeta Bionics, Inc. (BBNX) stock price, news, quote and history - Yahoo Finance UK
Beta Bionics, Inc. (BBNX) stock price, news, quote and history Yahoo Finance UK
BBNX Stock Drop Alert: Beta Bionics Stock Plummets 37% - globenewswire.com
BBNX Stock Drop Alert: Beta Bionics Stock Plummets 37% globenewswire.com
Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal - TradingView
Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal TradingView
BBNX Investor Alert: Beta Bionics, Inc. Securities Class Action Notice - Contact Levi & Korsinsky - PR Newswire
BBNX Investor Alert: Beta Bionics, Inc. Securities Class Action Notice - Contact Levi & Korsinsky PR Newswire
A 4:30 p.m. ET call will review Beta Bionics' third-quarter performance on Oct. 27. - Stock Titan
A 4:30 p.m. ET call will review Beta Bionics' third-quarter performance on Oct. 27. Stock Titan
BBNX Investor Alert: Johnson Fistel Encourages Beta Bionics, Inc. Investors to Contact the Firm Ahead of November 3, 2026 Lead Plaintiff Deadline - Morningstar
BBNX Investor Alert: Johnson Fistel Encourages Beta Bionics, Inc. Investors to Contact the Firm Ahead of November 3, 2026 Lead Plaintiff Deadline Morningstar
Beta Bionics (BBNX) Jumped, But What Is Behind The Latest Attention? - Simply Wall Street
Beta Bionics (BBNX) Jumped, But What Is Behind The Latest Attention? Simply Wall Street
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 3, 2026 in Beta Bionics, Inc. Lawsuit - BBNX - PR Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 3, 2026 in Beta Bionics, Inc. Lawsuit - BBNX PR Newswire
After selling shares under a trading plan, director Christy Jones holds 19,564 Beta Bionics (BBNX) shares. - Stock Titan
After selling shares under a trading plan, director Christy Jones holds 19,564 Beta Bionics (BBNX) shares. Stock Titan
Truist Raises Price Target on Beta Bionics to $28 From $23, Keeps Buy Rating - finance.yahoo.com
Truist Raises Price Target on Beta Bionics to $28 From $23, Keeps Buy Rating finance.yahoo.com
Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNX - Morningstar
Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNX Morningstar
BBNX Shareholder Alert: Beta Bionics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt - PR Newswire
BBNX Shareholder Alert: Beta Bionics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt PR Newswire
A year-long glucose monitor is expected to join an automated insulin system in Q4 - Stock Titan
A year-long glucose monitor is expected to join an automated insulin system in Q4 Stock Titan
BETA BIONICS, INC. (BBNX) SHAREHOLDER ALERT Bernstein - globenewswire.com
BETA BIONICS, INC. (BBNX) SHAREHOLDER ALERT Bernstein globenewswire.com
Robbins LLP Urges BBNX Stockholders to Contact the Firm for Information About the Class Action Against Beta Bionics, Inc. - PR Newswire
Robbins LLP Urges BBNX Stockholders to Contact the Firm for Information About the Class Action Against Beta Bionics, Inc. PR Newswire
BBNX Investors: Beta Bionics, Inc. Shares Declined By - globenewswire.com
BBNX Investors: Beta Bionics, Inc. Shares Declined By globenewswire.com
Beta Bionics (BBNX) Investors: Securities Fraud Class - globenewswire.com
Beta Bionics (BBNX) Investors: Securities Fraud Class globenewswire.com
Kaplan Fox Reminds Beta Bionics, Inc. (NASDAQ: BBNX) Investors With Significant Losses to Seek a Leadership Role Before Deadline on November 3, 2026 - The Globe and Mail
Kaplan Fox Reminds Beta Bionics, Inc. (NASDAQ: BBNX) Investors With Significant Losses to Seek a Leadership Role Before Deadline on November 3, 2026 The Globe and Mail
What Could Beta Bionics (BBNX) 2026 CGM Integration Mean For Its Diabetes Platform? - Simply Wall Street
What Could Beta Bionics (BBNX) 2026 CGM Integration Mean For Its Diabetes Platform? Simply Wall Street
BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit - PR Newswire
BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit PR Newswire